Sloan Sheldon sold SYRE
June 3, 2026 · Form 4 insider transaction
Sloan Sheldon sold 8,333 shares of Spyre Therapeutics, Inc. at $75.00 per share, a transaction worth $625.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,333
Price
$75.00
Total value
$625.0K
InsiderSloan Sheldon
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 3, 2026
Filing dateJune 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.